Articles on Big Pharma

Displaying 1 - 20 of 50 articles

Dozens of studies and numerous reviews have demonstrated the safety of vaccines. (Shutterstock)

Public health at risk when opinion trumps evidence

In an era when opinion often trumps evidence in public health issues, it's time to support and invest in evidence-based medicine to protect the public from dangerous, poorly informed beliefs.
Ohio is fighting to hold drug companies accountable for their role in the opioid epidemic. Bryan Woolston/Reuters

A look inside Ohio’s lawsuit against opioid manufacturers

The state of Ohio filed a lawsuit against opioid manufacturers. Will their legal arguments hold up in court – and what will it mean for other cities and states going after big pharma?
Now you can find out who’s wining and dining our doctors, nurses and pharmacists with publicly available data of drug company funded events. from www.shutterstock.com

Who’s paying for lunch? Here’s exactly how drug companies wine and dine our doctors

Drug companies funded more than 116,000 educational events for doctors over four years. Now you can find out exactly which companies footed the bills and how much they paid.
Medical panels are constantly lowering thresholds across many diseases, which results in more and more healthy people being diagnosed as sick. José Martín/Unsplash

How to rein in the widening disease definitions that label more healthy people as sick

More of us are labelled as sick with the constantly changing diagnostic cut-offs for diseases. Now an international expert panel has drafted a list of things to consider before setting new thresholds.
Martin Shkreli had victims long before he turned his hand to pharmaceuticals. Lucas Jackson/Reuters

Martin Shkreli and the outrage of inequality

The lack of transparency and accountability found in the hedge fund world is increasingly finding a home in the pharmaceutical sector, where more people care.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached. EPA/Erik S. Lesser

Why biologics were such a big deal in the Trans Pacific Partnership

Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.

Top contributors

More